Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Lett Appl Microbiol ; 49(6): 800-2, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19780961

ABSTRACT

AIMS: Oxalobacter formigenes is an oxalate-degrading intestinal bacterium that has been found in humans, cattle, sheep, rats and dogs. Its presence in the intestinal tract may be a protective factor against calcium oxalate urolithiasis because of its ability to degrade oxalate. The objective of this study was to determine whether O. formigenes could be detected in the faeces of healthy cats. METHODS AND RESULTS: A convenience sample of 28 cats was enrolled. Faecal samples were tested for oxc, a gene specific for O. formigenes, by real-time PCR. This gene was detected in 5/28 (18%) cats; however, the prevalence increased to 86% (24/28) with a modification of the methodology. CONCLUSIONS: Demonstrating the presence of O. formigenes in the faeces of healthy cats for the first time in this study. SIGNIFICANCE AND IMPACT OF THE STUDY: Future investigation of the role of this organism in the pathophysiology of calcium oxalate urolithiasis in cats is indicated.


Subject(s)
Feces/microbiology , Oxalobacter formigenes/isolation & purification , Animals , Cats , DNA, Bacterial/genetics , Genes, Bacterial , Oxalobacter formigenes/genetics , Polymerase Chain Reaction
3.
Vet Microbiol ; 101(3): 161-6, 2004 Jul 14.
Article in English | MEDLINE | ID: mdl-15223120

ABSTRACT

This study evaluated the ability of the lactic acid bacteria (LAB) component of canine and feline feces to degrade oxalate in vitro. Oxalate degradation by individual canine-origin LAB was also evaluated. The effects of various prebiotics on in vitro oxalate degradation by selected oxalate-degrading canine LAB was also evaluated. Canine fecal samples reduced oxalate levels by 78 +/- 12.2% (mean +/- S.D.; range: 44-97%, median: 81%). Feline results were similar, with oxalate reduction of 69.7 +/- 16.7% (mean +/- S.D.; range: 40-96%, median: 73%). Thirty-seven lactic acid bacteria were isolated from canine fecal samples. Mean oxalate degradation was 17.7 +/- 16.6% (mean +/- S.D.; range: 0-65%, median: 13%). No oxalate degradation was detected for four (11%) isolates, and 10/37 (27%) degraded less than 10% of oxalate. The effects of lactitol, arabinogalactan, guar gum, gum Arabic, inulin, maltodextrin or a commercial fructooligosaccharide (FOS) product on in vitro oxalate degradation by five canine LAB isolates were highly variable, even within the same bacterial species. Overall, in vitro degradation was significantly greater with guar gum compared to arabinogalactan (P < 0.05), gum Arabic (P < 0.05), and lactitol (P < 0.01). This study suggests that manipulation of the LAB component of the canine and feline gastrointestinal microflora may decrease intestinal oxalate, and correspondingly intestinal oxalate absorption and renal excretion, thus potentially reducing oxalate urolithiasis.


Subject(s)
Calcium Oxalate/metabolism , Cats/microbiology , Dogs/microbiology , Lactobacillus/metabolism , Animals , Cat Diseases/metabolism , Cat Diseases/microbiology , Dog Diseases/metabolism , Dog Diseases/microbiology , Feces/microbiology , Galactans/metabolism , Intestines/microbiology , Mannans/metabolism , Oligosaccharides/metabolism , Plant Gums , Probiotics/metabolism , Sugar Alcohols/metabolism , Urinary Calculi/metabolism , Urinary Calculi/microbiology , Urinary Calculi/veterinary
4.
J Vet Intern Med ; 15(4): 374-8, 2001.
Article in English | MEDLINE | ID: mdl-11467596

ABSTRACT

In this prospective study, feces of dogs with diarrhea were compared with feces of normal dogs for the presence of Clostridium difficile, C difficile toxins A and B, C perfringens, and C perfingens enterotoxin (CPE). C difficile toxins A, B, or both were present in feces of 18 of 87 (21%) dogs with diarrhea and 4 of 55 (7%) normal dogs (P = 0.03), whereas CPE was present in the feces of 24 of 87 (28%) dogs with diarrhea and 3 of 55 (5%) normal dogs (P = 0.01). C difficile was isolated from 2 of 87 (2%) dogs with diarrhea but was not isolated from the feces of 55 normal dogs, possibly because of poor survival of the organism in fecal samples. C perfringens was isolated from the feces of 23 of 24 (96%) CPE-positive dogs with diarrhea, 52 of 63 (83%) CPE-negative dogs with diarrhea, and 39 of 55 (71%) CPE-negative dogs with normal feces. No correlation was found between C perfringens spore number and the presence of CPE.


Subject(s)
Clostridioides difficile/isolation & purification , Clostridium perfringens/isolation & purification , Diarrhea/veterinary , Dog Diseases/microbiology , Animals , Bacterial Toxins/isolation & purification , Case-Control Studies , Diarrhea/microbiology , Dogs , Enterotoxins/isolation & purification , Enzyme-Linked Immunosorbent Assay/veterinary , Female , Male
5.
J Am Vet Med Assoc ; 218(9): 1436-9, 1421, 2001 May 01.
Article in English | MEDLINE | ID: mdl-11345306

ABSTRACT

Two adult cats from the same household developed acute diarrhea. Clostridium difficile toxins were detected in the feces of both cats, whereas other recognized causes of diarrhea were not identified. Supportive medical treatment and metronidazole were administered and both cats responded well. A fecal sample obtained from 1 of the affected cats after treatment and a fecal sample obtained from a clinically normal cat in the household did not contain C difficile toxins. The role of C difficile in enteric disease in cats has not been extensively studied and is unclear; however, our findings suggest that toxigenic strains of C difficile may cause diarrhea in cats.


Subject(s)
Cat Diseases/diagnosis , Clostridioides difficile/isolation & purification , Diarrhea/veterinary , Enterocolitis, Pseudomembranous/veterinary , Animals , Anti-Bacterial Agents/therapeutic use , Cat Diseases/drug therapy , Cat Diseases/microbiology , Cats , Diarrhea/drug therapy , Diarrhea/microbiology , Enterocolitis, Pseudomembranous/diagnosis , Enterocolitis, Pseudomembranous/drug therapy , Feces/microbiology , Female , Male , Metronidazole/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL